TD Asset Management’s Immunogen Inc IMGN Stock Holding History

TD Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-282,400	Closed	-$4.48M	–	1469
2023 Q3	$4.48M	Buy	282,400 +184,500	+188%	+$3.07M	0.01%	761
2023 Q2	$1.85M	Buy	+97,900	New	+$1.16M	﹤0.01%	985
2019 Q4	–	Sell	-13,633	Closed	-$33K	–	1429
2019 Q3	$33K	Hold	13,633	–	–	﹤0.01%	1331
2019 Q2	$30K	Sell	13,633 -46,318	-77%	-$110K	﹤0.01%	1320
2019 Q1	$162K	Sell	59,951 -3,882	-6%	-$16.8K	﹤0.01%	1317
2018 Q4	$306K	Hold	63,833	–	–	﹤0.01%	1302
2018 Q3	$604K	Sell	63,833 -8,500	-12%	-$81.7K	﹤0.01%	1251
2018 Q2	$704K	Buy	72,333 +16,733	+30%	+$176K	﹤0.01%	1202
2018 Q1	$585K	Buy	55,600 +6,900	+14%	+$68.2K	﹤0.01%	1163
2017 Q4	$312K	Buy	48,700 +11,300	+30%	+$69.7K	﹤0.01%	1260
2017 Q3	$286K	Buy	+37,400	New	+$249K	﹤0.01%	1242

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TD Asset Management's IMGN Position: Q4 2023 in Review

TD Asset Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 282,400 shares — an estimated $4.48M sold.

TD Asset Management first reported a position in IMGN in Q3 2017 and held it in 11 quarters. The position peaked at $4.48M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

TD Asset Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
TD Asset Management sold 282,400 Immunogen Inc shares in Q4 2023, an estimated $4.48M.
TD Asset Management first reported a position in Immunogen Inc in Q3 2017 and held it in 11 quarters.
TD Asset Management's Immunogen Inc position peaked at $4.48M in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.